Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of a Fourth Hexavalent Vaccine Dose During Primary Vaccination After Haematopoietic Stem Cell Transplantation

NCT03402776 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03402776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03402776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of a Fourth Hexavalent Vaccine Dose During Primary Vaccination After Haematopoietic Stem Cell Transplantation
Lead sponsor
University Hospital, Grenoble
Phase
Phase 3
Overall status
Unknown status
Start date
May 1, 2018
Completion date
May 1, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allograft, haemopoietic stem cell transplantation